Literature DB >> 15081536

CD45 isoforms in T cell signalling and development.

Louise McNeill1, Robin L Cassady, Samiramis Sarkardei, Joanne C Cooper, Geoffrey Morgan, Denis R Alexander.   

Abstract

The CD45 phosphotyrosine phosphatase is expressed on T cells as multiple isoforms due to alternative splicing. The panoply of isoforms expressed is tightly regulated during T cell development and on mature peripheral T cell subsets following activation. We describe the analysis of comparative CD45 isoform expression levels on thymic and T cell subsets from the C57BL/6 mouse. Only four isoforms were expressed at significant protein levels: CD45R0, CD45RB, CD45RBC and CD45RABC, although trace amounts of others may be present. The expression of CD45RBC was about nine-fold higher on CD8(+) than on CD4(+) peripheral T cells, whereas CD45R0 expression was higher on CD4(+) T cells. We provide a general overview of the current models that have been proposed to explain the molecular actions of the different CD45 isoforms. Achieving a thorough understanding of the biological reasons for the existence and tight regulation of CD45 isoform expression in immune cells remains one of the outstanding challenges in the CD45 research field.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15081536     DOI: 10.1016/j.imlet.2003.10.018

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  22 in total

Review 1.  T cells modulate glycans on CD43 and CD45 during development and activation, signal regulation, and survival.

Authors:  Mary C Clark; Linda G Baum
Journal:  Ann N Y Acad Sci       Date:  2012-01-30       Impact factor: 5.691

Review 2.  CD45: all is not yet crystal clear.

Authors:  Nick Holmes
Journal:  Immunology       Date:  2006-02       Impact factor: 7.397

3.  Multimolecular analysis of stable immunological synapses reveals sustained recruitment and sequential assembly of signaling clusters.

Authors:  Lars Philipsen; Thomas Engels; Kerstin Schilling; Slavyana Gurbiel; Klaus-Dieter Fischer; Kerry Tedford; Burkhart Schraven; Matthias Gunzer; Peter Reichardt
Journal:  Mol Cell Proteomics       Date:  2013-06-10       Impact factor: 5.911

4.  Lactobacillus reuteri DSM 17938 differentially modulates effector memory T cells and Foxp3+ regulatory T cells in a mouse model of necrotizing enterocolitis.

Authors:  Yuying Liu; Dat Q Tran; Nicole Y Fatheree; J Marc Rhoads
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-05-22       Impact factor: 4.052

Review 5.  CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells.

Authors:  Michelle L Hermiston; Julie Zikherman; Jing W Zhu
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

6.  N- and O-glycans modulate galectin-1 binding, CD45 signaling, and T cell death.

Authors:  Lesley A Earl; Shuguang Bi; Linda G Baum
Journal:  J Biol Chem       Date:  2009-11-17       Impact factor: 5.157

7.  The Bromodomain Protein 4 Contributes to the Regulation of Alternative Splicing.

Authors:  Sheetal Uppal; Anne Gegonne; Qingrong Chen; Petria S Thompson; Dan Cheng; Jie Mu; Daoud Meerzaman; Hari S Misra; Dinah S Singer
Journal:  Cell Rep       Date:  2019-11-19       Impact factor: 9.423

8.  The structural wedge domain of the receptor-like tyrosine phosphatase CD45 enforces B cell tolerance by regulating substrate specificity.

Authors:  Julie Zikherman; Ramya Parameswaran; Michelle Hermiston; Arthur Weiss
Journal:  J Immunol       Date:  2013-02-08       Impact factor: 5.422

9.  CD45RO enriches for activated, highly mutated human germinal center B cells.

Authors:  Stephen M Jackson; Natessa Harp; Darshna Patel; Jeffrey Zhang; Savannah Willson; Yoon J Kim; Christian Clanton; J Donald Capra
Journal:  Blood       Date:  2007-07-20       Impact factor: 22.113

10.  An extracatalytic function of CD45 in B cells is mediated by CD22.

Authors:  Sarah Coughlin; Mark Noviski; James L Mueller; Ammarina Chuwonpad; William C Raschke; Arthur Weiss; Julie Zikherman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.